These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Catastrophic antiphospholipid syndrome in a community-acquired methicillin-resistant Staphylococcus aureus infection: a review of pathogenesis with a case for molecular mimicry. Martin E; Winn R; Nugent K Autoimmun Rev; 2011 Feb; 10(4):181-8. PubMed ID: 20920612 [TBL] [Abstract][Full Text] [Related]
9. Catastrophic cerebral antiphospholipid syndrome presenting as cerebral infarction with haemorrhagic transformation after sudden withdrawal of warfarin in a patient with primary antiphospholipid syndrome. Wani AM; Hussain WM; Mejally MA; Ali KS; Raja SH; Maimani WA; Bafaraj MG; Bashraheel A; Akhtar M; Khoujah AM BMJ Case Rep; 2010; 2010():. PubMed ID: 22242060 [TBL] [Abstract][Full Text] [Related]
10. The catastrophic antiphospholipid (Asherson's) syndrome. Asherson RA Autoimmun Rev; 2006 Dec; 6(2):64-7. PubMed ID: 17138244 [TBL] [Abstract][Full Text] [Related]
11. Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations. Blank M; Shoenfeld Y Clin Immunol; 2004 Aug; 112(2):190-9. PubMed ID: 15240163 [TBL] [Abstract][Full Text] [Related]
13. Clinical and laboratory features of the catastrophic antiphospholipid syndrome. Stojanovich L; Marisavljevic D; Rovensky J; Djokovich A; Kozáková D; Milinic N Clin Rev Allergy Immunol; 2009 Jun; 36(2-3):74-9. PubMed ID: 19052923 [TBL] [Abstract][Full Text] [Related]
14. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry". Cervera R; Bucciarelli S; Plasín MA; Gómez-Puerta JA; Plaza J; Pons-Estel G; Shoenfeld Y; Ingelmo M; Espinos G; J Autoimmun; 2009; 32(3-4):240-5. PubMed ID: 19324520 [TBL] [Abstract][Full Text] [Related]
15. Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death, and prognostic factors. Espinosa G; Bucciarelli S; Asherson RA; Cervera R Semin Thromb Hemost; 2008 Apr; 34(3):290-4. PubMed ID: 18720310 [TBL] [Abstract][Full Text] [Related]
16. Microvascular and microangiopathic antiphospholipid-associated syndromes ("MAPS"): semantic or antisemantic? Asherson RA; Cervera R Autoimmun Rev; 2008 Jan; 7(3):164-7. PubMed ID: 18190872 [TBL] [Abstract][Full Text] [Related]
17. Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients. Asherson RA; Espinosa G; Cervera R; Gómez-Puerta JA; Musuruana J; Bucciarelli S; Ramos-Casals M; Martínez-González AL; Ingelmo M; Reverter JC; Font J; Triplett DA Ann Rheum Dis; 2005 Jun; 64(6):943-6. PubMed ID: 15897312 [TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid syndrome (APS): where does it come from? Sherer Y; Blank M; Shoenfeld Y Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):1071-8. PubMed ID: 18068862 [TBL] [Abstract][Full Text] [Related]
19. The role of infectious diseases in the catastrophic antiphospholipid syndrome. Garcia-Carrasco M; Mendoza-Pinto C; Macias-Diaz S; Vazquez de Lara F; Etchegaray-Morales I; Galvez-Romero JL; Mendez-Martinez S; Cervera R Autoimmun Rev; 2015 Nov; 14(11):1066-71. PubMed ID: 26209907 [TBL] [Abstract][Full Text] [Related]
20. Acute respiratory distress syndrome and other unusual manifestations of the catastrophic antiphospholipid (Asherson's) syndrome. Asherson RA Isr Med Assoc J; 2004 Jun; 6(6):360-3. PubMed ID: 15214465 [No Abstract] [Full Text] [Related] [Next] [New Search]